One of the most significant hurdles facing the Renal Denervation Market is the high cost of the procedure and the ongoing struggle for comprehensive insurance reimbursement. In many countries, the upfront cost of the catheter and the specialized ablation generator makes it an expensive option compared to daily medication. Information regarding reimbursement policies and market restraints can be found in the Renal Denervation Market analysis.

People also ask: Is renal denervation covered by insurance? Why is renal denervation so expensive? While the upfront cost is high, advocates argue that the procedure pays for itself over time by reducing the incidence of high-cost events like strokes and hospitalizations for heart failure.

In 2025, a major milestone was reached when the CMS initiated a national coverage analysis in the U.S., which could lead to standardized Medicare coverage. Such decisions are vital for moving the market from "niche" to "standard of care," particularly for the elderly population.